Arcutis Biotherapeutics had a revenue of 99.22M in the quarter ending Sep 30, 2025, with 21.74%. This bring the company's revenue in the last twelve months to 317.93M, Decreased 20.67%. In the fiscal year ending Dec 31, 2024, Arcutis Biotherapeutics had annual revenue of 196.54M with 229.74% growth.